169
Views
3
CrossRef citations to date
0
Altmetric
Articles

Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens—Tumor Metastasis by Migration?

ORCID Icon, , , , &
Pages 1382-1388 | Received 27 Nov 2016, Accepted 23 Apr 2017, Published online: 16 Jun 2017

References

  • Vora GK, Demirci H, Marr B, Mruthyunjaya P. Advances in the management of conjunctival melanoma. Surv Ophthalmol 2017;62(1):26–42.
  • Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival malignant melanoma: a review and update. Expert Rev Ophthalmol 2014;9(3):185–204.
  • Hu DN, Yu G, McCormick SA, Finger PT. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas. Am J Ophthalmol 2008;145(3):418–423.
  • Miller CV, Cook IS, Jayaramachandran R, Tyers AG. Spontaneous regression of a conjunctival malignant melanoma. Orbit 2014;33(2):139–141.
  • Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 2002;86(2):163–167.
  • Fuchs U, Kivela T, Liesto K, Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer 1989;59(2):261–267.
  • Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci 2005;46(1):75–82.
  • Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000;118(11):1497–1507.
  • Tuomaala S, Eskelin S, Tarkkanen A, Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci 2002; 43(11):3399–3408.
  • De Potter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 1993;77(10):624–630.
  • Albreiki DH, Gilberg SM, Farmer JP. Conjunctival malignant melanoma: a rare variant and review of important diagnostic and therapeutic considerations. Saudi J Ophthalmol 2012;26(2):151–156.
  • Kimura K, Usui Y, Goto H. Clinical findings and prognosis of 11 cases of conjunctival malignant melanoma. Nihon Ganka Gakkai Zasshi 2012;116(5):503–509.
  • Costea CF, Anghel K, Dimitriu G, Dumitrescu GF, Faiyad Z, Dumitrescu AM, et al. Anatomoclinical aspects of conjunctival malignant metastatic melanoma. Rom J Morphol Embryol 2014;55(3):933–937.
  • Corrales RM, Calonge M, Herreras JM, Saez V, Mayo A, Chaves FJ. Levels of mucin gene expression in normal human conjunctival epithelium in vivo. Curr Eye Res 2003;27(5):323–328.
  • Hodges RR, Dartt DA. Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins. Exp Eye Res 2013;117:62–78.
  • Yu DF, Chen Y, Han JM, Zhang H, Chen XP, Zou WJ, et al. MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjogren syndrome patients. Exp Eye Res 2008;86(2):403–411.
  • Corrales RM, Galarreta DJ, Herreras JM, Calonge M, Chaves FJ. Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes. Arch Soc Esp Oftalmol 2003; 78(7):375–381.
  • Ellingham RB, Berry M, Stevenson D, Corfield AP. Secreted human conjunctival mucus contains MUC5AC glycoforms. Glycobiology 1999;9(11):1181–1189.
  • Overmoyer BA. Inflammatory breast cancer: novel preoperative therapies. Clin Breast Cancer 2010;10(1):27–32.
  • Carraway KL, Theodoropoulos G, Kozloski GA, Carothers Carraway CA. Muc4/MUC4 functions and regulation in cancer. Future Oncol 2009;5(10):1631–1640.
  • Gronnier C, Bruyere E, Lahdaoui F, Jonckheere N, Perrais M, Leteurtre E, et al. The MUC1 mucin regulates the tumorigenic properties of human esophageal adenocarcinomatous cells. Biochim Biophys Acta 2014;1843(11):2432–2437.
  • Bafna S, Kaur S, Momi N, Batra SK. Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br J Cancer 2009;101(7):1155–1161.
  • Skrypek N, Duchene B, Hebbar M, Leteurtre E, Van Seuningen I, Jonckheere N. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene 2013;32(13):1714–1723.
  • Wissniowski TT, Meister S, Hahn EG, Kalden JR, Voll R, Ocker M. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells. Int J Oncol 2012;40(5):1581–1589.
  • Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK. MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies. Cancer Lett 2010;295(1):69–84.
  • Paulsen F, Jager K, Worlitzsch D, Brauer L, Schulze U, Schafer G, et al. Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines. Ann Anat 2008;190(1):59–70.
  • Pauklin M, Kakkassery V, Steuhl KP, Meller D. Expression of membrane-associated mucins in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium. Curr Eye Res 2009;34(3):221–230.
  • Albertsmeyer AC, Kakkassery V, Spurr-Michaud S, Beeks O, Gipson IK. Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res 2010;90(3):444–451.
  • Gipson IK, Spurr-Michaud S, Argueso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003;44(6):2496–2506.
  • Danjo Y, Watanabe H, Tisdale AS, George M, Tsumura T, Abelson MB, et al. Alteration of mucin in human conjunctival epithelia in dry eye. Invest Ophthalmol Vis Sci 1998;39(13):2602–2609.
  • Argueso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope. Invest Ophthalmol Vis Sci 2003;44(6):2487–2495.
  • Theodoropoulos G, Carraway CA, Carraway KL. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury. J Cell Biochem 2009;107(1):112–122.
  • Gipson IK, Blalock T, Tisdale A, Spurr-Michaud S, Allcorn S, Stavreus-Evers A, et al. MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol Reprod 2008;78(1):134–142.
  • Cai H, Palitzsch B, Hartmann S, Stergiou N, Kunz H, Schmitt E, et al. Antibody induction directed against the tumor-associated MUC4 glycoprotein. Chembiochem 2015;16(6):959–967.
  • Gao L, Liu J, Zhang B, Zhang H, Wang D, Zhang T, et al. Functional MUC4 suppress epithelial-mesenchymal transition in lung adenocarcinoma metastasis. Tumour Biol 2014;35(2):1335–1341.
  • Robertson MD, Zumberg M. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature. Am J Hematol 2007;82(3):224–228.
  • Lindboe CF, Torp SH Comparison of Ki-67 equivalent antibodies. J Clin Pathol 2002;55(6):467–471.
  • Inatomi T, Spurr-Michaud S, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci 1995;36(9):1818–1827.
  • Pflugfelder SC, Liu Z, Monroy D, Li DQ, Carvajal ME, Price-Schiavi SA, et al. Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci 2000;41(6):1316–1326.
  • Inatomi T, Spurr-Michaud S, Tisdale AS, Zhan Q, Feldman ST, Gipson IK. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci 1996;37(8):1684–1692.
  • Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye 2009;23(4):801–809.
  • Zhang J, Carraway CA, Carraway KL. Muc4 expression during blood vessel formation in damaged rat cornea. Curr Eye Res 2006;31(12):1011–1014.
  • Kamikawa Y, Kanmura Y, Hamada T, Yamada N, Macha MA, Batra SK, et al. Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma. Int J Clin Oncol 2014;20(2):298–307.
  • Hamada T, Wakamatsu T, Miyahara M, Nagata S, Nomura M, Kamikawa Y, et al. MUC4: a novel prognostic factor of oral squamous cell carcinoma. Int J Cancer 2012;130(8):1768–1776.
  • Kusafuka K, Muramatsu K, Iida Y, Mori K, Miki T, Suda T, et al. MUC expression in adenosquamous carcinoma of the head and neck regions of Japanese patients: immunohistochemical analysis. Pathol Int 2014;64(3):104–114.
  • Ansari D, Urey C, Gundewar C, Bauden MP, Andersson R. Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases. Scand J Gastroenterol 2013;48(10):1183–1187.
  • Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, Chakraborty S, Jain M, Pai P, et al. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS One 2013;8(2):e54455.
  • Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, et al. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One 2012;7(11):e49251.
  • Lee HK, Cho MS, Kim TH. Prognostic significance of muc4 expression in gallbladder carcinoma. World J Surg Oncol 2012;10:224.
  • Nam KH, Noh TW, Chung SH, Lee SH, Lee MK, Hong SW, et al. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Thyroid 2011;21(7):745–750.
  • Yeh CN, Pang ST, Wu RC, Chen TW, Jan YY, Chen MF. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy. Oncol Rep 2009;21(1):49–56.
  • Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K, et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 2006; 12 (14 Pt 1): 4257–4264.
  • Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S, et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. J Thorac Oncol 2013;8(4):398–407.
  • Alos L, Lujan B, Castillo M, Nadal A, Carreras M, Caballero M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 2005;29(6):806–813.
  • Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, et al. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate 2006;66(4):421–429.
  • Menon BB, Kaiser-Marko C, Spurr-Michaud S, Tisdale AS, Gipson IK. Suppression of Toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC1 and MUC16. Mucosal Immunol 2015;8(5):1000–1008.
  • Imbert Y, Jumblatt MM, Foulks GN, Couzin EG, Steele PS, Young WW Jr. Expression in human ocular surface tissues of the GalNAc-transferases that initiate mucin-type O-glycosylation. Cornea 2006;25(10):1193–1199.
  • Argueso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci 2002;43(4):1004–1011.
  • Dogru M, Asano-Kato N, Tanaka M, Igarashi A, Shimmura S, Shimazaki J, et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res 2005;30(10):897–908.
  • Corfield AP, Donapaty SR, Carrington SD, Hicks SJ, Schauer R, Kohla G. Identification of 9-O-acetyl-N-acetylneuraminic acid in normal canine pre-ocular tear film secreted mucins and its depletion in Keratoconjunctivitis sicca. Glycoconj J 2005;22(7–9):409–416.
  • Sugars: AP. an exceptional protective coat for the ocular surface. Arch Soc Esp Oftalmol 2008;83(5):287–290.
  • Guzman-Aranguez A, Argueso P. Structure and biological roles of mucin-type O-glycans at the ocular surface. Ocul Surf 2010;8(1):8–17.
  • Heimann H, Coupland SE, Gochman R, Hellmich M, Foerster MH. Alterations in expression of mucin, tenascin-c and syndecan-1 in the conjunctiva following retinal surgery and plaque radiotherapy. Graefes Arch Clin Exp Ophthalmol 2001;239(7):488–495.
  • Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, et al. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci 2011;52(10):7074–7083.
  • Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, et al. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology 2011;118(12):2351–2360.
  • Cao R, Wang TT, DeMaria G, Sheehan JK, Kesimer M. Mapping the protein domain structures of the respiratory mucins: a mucin proteome coverage study. J Proteome Res 2012;11(8):4013–4023.
  • Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis–correlation in invasive breast carcinoma. N Engl J Med 1991;324(1):1–8.
  • Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 1999;85(3):562–582.
  • Nalwoga H, Ahmed L, Arnes JB, Wabinga H, Akslen LA. Strong Expression of Hypoxia-Inducible Factor-1alpha (HIF-1alpha) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer. PLoS One 2016;11(1):e0146823.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.